Health & Behavior

Research

The Latest

UC San Diego Researchers Awarded $889,000 for Cystinosis Studies

Two researchers at the University of California, San Diego School of Medicine have been awarded grants totaling more than $889,000 from the Cystinosis Research Foundation (CRF) to investigate better treatments and a cure for cystinosis. A rare and deadly genetic disease, cystinosis affects about 500 children and young adults in the United States and 2,000 worldwide. The most recent grants bring the total funding from CRF to UC San Diego School of Medicine researchers to more than $5.5 million since 2003.

Two Studies Identify Potential New Drug for Crohn’s Disease and Ulcerative Colitis

Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn’s disease and ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The findings, published in two papers, will appear in the August 22 issue of the New England Journal of Medicine (NEJM).

UC San Diego Ranked 14th Best University in World by Shanghai Jiao Tong University

The University of California, San Diego is ranked the 14th best university in the world, up from 15th place last year, and its life sciences and engineering programs are ranked 7th and 13th respectively, according to the 2013 Academic Ranking of World Universities (ARWU).

SDSC Launches ‘Sherlock’ To Solve Complex National Challenges

The San Diego Supercomputer Center (SDSC) at the University of California, San Diego, along with small business partners SD Technology and Chickasaw Nation Industries, have brought together their extensive portfolio of information technology services for healthcare and government under the ‘Sherlock’ brand in an effort to serve federal, state, and local governments as well as universities nationwide.

Clinical Trial Evaluates New Minimally Invasive Rectal Cancer Surgery

Surgeons at the University of California, San Diego School of Medicine are evaluating a new, combined surgery technique to remove cancerous tumors from the rectum. The hybrid technique uses the body’s natural opening to remove malignancies and diseased tissue while also performing reconstruction.

Mountain High: Genetic Adaptation for High Altitudes Identified

Research led by scientists from the University of California, San Diego has decoded the genetic basis of chronic mountain sickness (CMS) or Monge’s disease. Their study provides important information that validates the genetic basis of adaptation to high altitudes, and provides potential targets for CMS treatment.